Novozymes A/S (NZYM B)

Basic

  • Market Cap

    DKK 98.66B

  • EV

    DKK 105.05B

  • Shares Out

    277.06M

  • Revenue

    DKK 17.83B

  • Employees

    6,820

Margins

  • Gross

    54.27%

  • EBITDA

    30.6%

  • Operating

    24.16%

  • Pre-Tax

    22.61%

  • Net

    18%

  • FCF

    7.94%

Returns (5Yr Avg)

  • ROA

    11.48%

  • ROE

    27.09%

  • ROCE

    24.19%

  • ROIC

    17.11%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    DKK 376.54

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    DKK 64.38

  • Earnings (Dil)

    DKK 11.55

  • FCF

    DKK 5.09

  • Book Value

    DKK 52.28

Growth (CAGR)

  • Rev 3Yr

    7.63%

  • Rev 5Yr

    4.43%

  • Rev 10Yr

    4.37%

  • Dil EPS 3Yr

    1.8%

  • Dil EPS 5Yr

    1.29%

  • Dil EPS 10Yr

    5.55%

  • Rev Fwd 2Yr

    3.72%

  • EBITDA Fwd 2Yr

    3.5%

  • EPS Fwd 2Yr

    0.54%

  • EPS LT Growth Est

    10.4%

Dividends

  • Yield

    —

  • Payout

    51.77%

  • DPS

    DKK 6

  • DPS Growth 3Yr

    4.55%

  • DPS Growth 5Yr

    5.92%

  • DPS Growth 10Yr

    10.55%

  • DPS Growth Fwd 2Yr

    3.99%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

14,390.0

14,374.0

14,012.0

14,951.0

17,553.0

17,825.0

Total Revenues % Chg.

-1.0%

-0.1%

-2.5%

6.7%

17.4%

5.7%

Cost of Goods Sold, Total

6,089.0

6,387.0

6,159.0

6,313.0

7,963.0

8,152.0

Gross Profit

8,301.0

7,987.0

7,853.0

8,638.0

9,590.0

9,673.0

Selling General & Admin Expenses, Total

2,345.0

2,454.0

2,291.0

2,795.0

3,223.0

3,316.0

Stock-Based Compensation

-11.0

5.0

8.0

33.0

-25.0

-25.0

R&D Expenses

1,852.0

1,966.0

1,905.0

1,982.0

1,986.0

2,013.0

Other Operating Expenses

-43.0

-26.0

-14.0

-66.0

-75.0

63.0

Other Operating Expenses, Total

4,143.0

4,399.0

4,190.0

4,744.0

5,109.0

5,367.0

Operating Income

4,158.0

3,588.0

3,663.0

3,894.0

4,481.0

4,306.0

Interest Expense, Total

-13.0

-86.0

-63.0

-102.0

-102.0

-124.0

Interest And Investment Income

10.0

90.0

10.0

18.0

18.0

18.0

Net Interest Expenses

-3.0

4.0

-53.0

-84.0

-84.0

-106.0

Income (Loss) On Equity Invest.

-17.0

-5.0

-4.0

-4.0

-7.0

-15.0

Currency Exchange Gains (Loss)

-89.0

-205.0

-35.0

-4.0

-330.0

-160.0

Other Non Operating Income (Expenses)

-36.0

-29.0

-31.0

-20.0

-99.0

-366.0

EBT, Excl. Unusual Items

4,013.0

3,353.0

3,540.0

3,782.0

3,961.0

3,659.0

Merger & Related Restructuring Charges

—

—

-29.0

—

-68.0

-411.0

Gain (Loss) On Sale Of Investments

—

—

—

—

468.0

468.0

Gain (Loss) On Sale Of Assets

—

194.0

42.0

122.0

—

—

Asset Writedown

-77.0

-48.0

-32.0

-42.0

-28.0

-28.0

Other Unusual Items

—

300.0

—

62.0

223.0

343.0

EBT, Incl. Unusual Items

3,936.0

3,799.0

3,521.0

3,924.0

4,556.0

4,031.0

Income Tax Expense

709.0

644.0

695.0

779.0

870.0

810.0

Earnings From Continuing Operations

3,227.0

3,155.0

2,826.0

3,145.0

3,686.0

3,221.0

Minority Interest

-1.0

-1.0

-1.0

1.0

-10.0

-12.0

Net Income

3,226.0

3,154.0

2,825.0

3,146.0

3,676.0

3,209.0

Net Income to Common Incl Extra Items

3,226.0

3,154.0

2,825.0

3,146.0

3,676.0

3,209.0

Net Income to Common Excl. Extra Items

3,226.0

3,154.0

2,825.0

3,146.0

3,676.0

3,209.0

Total Shares Outstanding

287.6

281.3

279.3

277.1

276.6

277.1

Weighted Avg. Shares Outstanding

290.4

285.1

280.4

277.9

276.6

276.9

Weighted Avg. Shares Outstanding Dil

292.4

286.6

282.0

280.2

278.7

277.8

EPS

11.1

11.1

10.1

11.3

13.3

11.6

EPS Diluted

11.0

11.0

10.0

11.2

13.2

11.5

EBITDA

5,101.0

4,584.0

4,699.0

5,061.0

5,721.0

5,455.0